Processa Pharmaceuticals Announces the Appointment of Dr. Khalid Islam to Its Board of Directors
05 nov. 2020 09h15 HE
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to improve...